In response to the concerning escalation of drug prices in Nigeria, Prof. Muhammad Pate, the Coordinating Minister of Health and Social Welfare, announced that the Federal Government is set to issue an executive order aimed at curbing the soaring costs of pharmaceuticals. Prof. Pate disclosed this during the third edition of the ministerial press briefing series initiated by the Ministry of Information in Abuja.
The executive order, identified as a short-term measure, is part of the government’s broader strategy to tackle the issue. Prof. Pate outlined mid to long-term goals, which include the domestication of imported drugs within the next three years in collaboration with the Ministry of Industry, Trade, and Investment.
Highlighting infrastructure developments to fortify the pharmaceutical sector nationwide, Prof. Pate revealed plans for the commissioning of pharmaceutical-grade warehouses at the federal level in April 2024.
These initiatives aim to address challenges such as depreciating currency, hoarding, importation of drugs, and high tariffs on pharmaceutical imports, which experts in the pharmaceutical industry attribute to the escalating drug prices.
The Minister of State for Health and Social Welfare, Dr. Tunji Alausa, previously indicated that President Bola Tinubu would soon sign the executive order to provide immediate relief to Nigerians affected by the high cost of pharmaceuticals.
Furthermore, Prof. Pate highlighted the government’s efforts in advancing healthcare data management, including the implementation of the Warehousing Management Information System (WMIS) in pharmaceutical-grade warehouses.
This infrastructure development is expected to enhance accountability, transparency, and the potency of public health medicines and other health commodities.
In addition, the Federal Government has taken strides in promoting medical industrialization through strategic partnerships and funding initiatives.
Notably, the Ministry secured a $1 billion pledge from Afriexim bank, alongside commitments from foreign partners, to support endeavors in this regard.
These measures underscore the government’s commitment to addressing the rising costs of pharmaceuticals, enhancing healthcare data management, and promoting medical industrialization to improve health outcomes and ensure the accessibility of essential healthcare services to all citizens across the nation.
